To evaluate the value of detective system (C-12) of multiple tumor markers protein biochip for clinical staging, pathologic classification and prognostic evaluation in lung cancer.
探讨多种肿瘤标志物蛋白芯片检测系统(C鄄12)在鉴别肺癌的临床分期、病理类型和预后评估中的价值。
The study of staging lung cancer is the base of the clinical study.
肺癌的临床分期研究是肺癌临床研究的基础。
Objective To evaluate the clinical value of transbranchial needle aspiration (TBNA) in the pre-operative staging of lung cancer.
目的探讨经支气管针吸活检（TBNA）在肺癌分期中的临床应用价值。
Conclusion TBNA for lymph node staging and pathologic typing of lung cancer is a safe, simple and economic method with high accuracy and high clinical application value.
结论经TBNA进行肺癌淋巴结分期、病理分型均有较高准确率，具有较高的临床实用价值。
ObjectiveTo investigate the Clinical significance of serum CEA, CYFRA21-1 and NSE in patients with non-small cell lung cancer on Diagnosis, Staging, monitoring effect and judging prognosis.
目的探讨CEA . CYFRA21 - 1及NSE检测在非小细胞肺癌患者的诊断分期、疗效监测及预后判断等方面的临床意义。
ObjectiveTo investigate the Clinical significance of serum CEA, CYFRA21-1 and NSE in patients with non-small cell lung cancer on Diagnosis, Staging, monitoring effect and judging prognosis.
目的探讨CEA . CYFRA21 - 1及NSE检测在非小细胞肺癌患者的诊断分期、疗效监测及预后判断等方面的临床意义。
应用推荐